Published in Biochem Pharmacol on May 15, 1991
Structure-activity relationships of N6-benzyladenosine-5'-uronamides as A3-selective adenosine agonists. J Med Chem (1994) 2.47
Adenosine receptors: pharmacology, structure-activity relationships, and therapeutic potential. J Med Chem (1992) 2.01
Adenosine A1 and A2 receptors: structure--function relationships. Med Res Rev (1992) 1.62
Adenosine receptor prodrugs: synthesis and biological activity of derivatives of potent, A1-selective agonists. J Pharm Sci (1994) 0.96
Attenuation of ischemic liver injury by augmentation of endogenous adenosine. Transplantation (1997) 0.95
The diuretic action of 8-cyclopentyl-1,3-dipropylxanthine, a selective A1 adenosine receptor antagonist. Br J Pharmacol (1993) 0.91
Deoxyribose analogues of N6-cyclopentyladenosine (CPA): partial agonists at the adenosine A1 receptor in vivo. Br J Pharmacol (1995) 0.81
The physiological activity of adenine compounds with especial reference to their action upon the mammalian heart. J Physiol (1929) 23.79
Is there a basis for distinguishing two types of P2-purinoceptor? Gen Pharmacol (1985) 9.20
Extracellular ATP: effects, sources and fate. Biochem J (1986) 8.45
Characterization of the A2 adenosine receptor labeled by [3H]NECA in rat striatal membranes. Mol Pharmacol (1986) 4.15
Cardiovascular purinoceptors. Physiol Rev (1990) 3.70
Adenosine receptors: targets for future drugs. J Med Chem (1982) 3.44
Adenosine receptors and behavioral actions of methylxanthines. Proc Natl Acad Sci U S A (1981) 2.66
Dipyridamole inhibition of adenosine metabolism in human blood. Eur J Pharmacol (1983) 2.46
A proposed role for adenosine in the regulation of renal hemodynamics and renin release. Am J Physiol (1982) 1.39
Receptors for ATP in rat sensory neurones: the structure-function relationship for ligands. Br J Pharmacol (1988) 1.38
Increased adenosine concentration in blood from ischemic myocardium by AICA riboside. Effects on flow, granulocytes, and injury. Circulation (1989) 1.37
2-(Arylalkylamino)adenosin-5'-uronamides: a new class of highly selective adenosine A2 receptor ligands. J Med Chem (1990) 1.34
Tissue content of adenosine, inosine and hypoxanthine in the rat kidney after ischemia and postischemic recirculation. Pflugers Arch (1977) 1.27
Structure-activity profile of a series of novel triazoloquinazoline adenosine antagonists. J Med Chem (1988) 1.23
Antagonistic effects of theophylline and adenosine on adrenergic neuroeffector transmission in the rabbit kidney. Circ Res (1978) 1.19
Effects of adenosine compounds on renal function and renin secretion in dogs. Circ Res (1970) 1.18
Comparison of the behavioral effects of adenosine agonists and dopamine antagonists in mice. Psychopharmacology (Berl) (1989) 1.17
Consequences of activation and adenosine-mediated inhibition of granulocytes during myocardial ischemia. Fed Proc (1987) 1.17
Adenosine as a possible mediator of metabolic control of glomerular filtration rate. Int J Biochem (1980) 1.10
N6-[2-(3,5-dimethoxyphenyl)-2-(2-methylphenyl)ethyl]adenosine and its uronamide derivatives. Novel adenosine agonists with both high affinity and high selectivity for the adenosine A2 receptor. J Med Chem (1988) 1.09
The effect of theophylline ethylene diamine on renal function in control subjects and in patients with congestive heart failure. J Clin Invest (1949) 1.08
Effect of the adenosine antagonist 8-phenyltheophylline on glycerol-induced acute renal failure in the rat. Br J Pharmacol (1986) 1.06
N6-substituted N-alkyladenosine-5'-uronamides: bifunctional ligands having recognition groups for A1 and A2 adenosine receptors. J Med Chem (1986) 1.06
Cardiovascular effects of adenosine in man; possible clinical implications. Prog Neurobiol (1986) 1.06
Concentration dependency of the renal vascular and renin secretory responses to adenosine receptor agonists. J Pharmacol Exp Ther (1985) 1.01
N6-(2,2-diphenylethyl)adenosine, a novel adenosine receptor agonist with antipsychotic-like activity. J Med Chem (1987) 0.94
Evidence that a novel 8-phenyl-substituted xanthine derivative is a cardioselective adenosine receptor antagonist in vivo. J Cardiovasc Pharmacol (1987) 0.94
Non-xanthine heterocycles: activity as antagonists of A1- and A2-adenosine receptors. Biochem Pharmacol (1988) 0.90
N-acyl-gamma-glutamyl derivatives of sulfamethoxazole as models of kidney-selective prodrugs. J Pharmacol Exp Ther (1980) 0.89
Adenosine is required for myocardial insulin responsiveness in vivo. Diabetes (1988) 0.88
Halogenated pyrrolopyrimidine analogues of adenosine from marine organisms: pharmacological activities and potent inhibition of adenosine kinase. Biochem Pharmacol (1984) 0.88
Functional renal insufficiency: role of adenosine. Biol Neonate (1988) 0.87
Adenosine stimulates sodium transport in kidney A6 epithelia in culture. Am J Physiol (1985) 0.86
Adenosine receptor prodrugs: towards kidney-selective dialkylxanthines. J Pharmacol Exp Ther (1989) 0.86
CGP 22979A, a renal vasodilator with natriuretic properties. J Pharmacol Exp Ther (1985) 0.85
N6-bicycloalkyladenosines with unusually high potency and selectivity for the adenosine A1 receptor. J Med Chem (1989) 0.83
Coronary and cardiohemodynamic effects of 2-phenylamino-adenosine (CV-1808) in anesthetized dogs and cats. Arzneimittelforschung (1980) 0.82
Drug latentiation by gamma-glutamyl transpeptidase. J Med Chem (1982) 0.81
Effect of pentoxifylline on the ischemic rat kidney monitored by 31P NMR spectroscopy in vivo. Biomed Biochim Acta (1988) 0.81
Sleep improvement in dogs after oral administration of mioflazine, a nucleoside transport inhibitor. Psychopharmacology (Berl) (1987) 0.80
The adenosine analogue and cerebral protecting agent, AMG-1, has no effect on delayed neuronal death following ischemia. Methods Find Exp Clin Pharmacol (1989) 0.77
Impaired blood flow autoregulation in nonfiltering kidneys: effects of theophylline administration. Proc Soc Exp Biol Med (1983) 0.77
The role of adenosine in HgCl2-induced acute renal failure in rats. Am J Physiol (1990) 0.77
C2,N6-disubstituted adenosines: synthesis and structure-activity relationships. J Med Chem (1989) 0.76
The sequence of the human genome. Science (2001) 101.55
Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood (2000) 9.24
Nomenclature and classification of purinoceptors. Pharmacol Rev (1994) 5.32
A Critical Study of the Methods of Estimating Cholesterol and Allied Substances. Biochem J (1921) 4.58
A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto. J Clin Epidemiol (1988) 4.41
Regulation of elongation factor 2 kinase by p90(RSK1) and p70 S6 kinase. EMBO J (2001) 4.40
Lymphocyte trafficking and regional immunity. Adv Immunol (1999) 4.21
[3H]CGS 21680, a selective A2 adenosine receptor agonist directly labels A2 receptors in rat brain. J Pharmacol Exp Ther (1989) 4.18
Distribution of NHS funds between fundholding and non-fundholding practices. BMJ (1994) 4.05
Enrichment of gene-coding sequences in maize by genome filtration. Science (2003) 3.41
Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group. Am J Kidney Dis (2000) 3.37
Alternate-day prednisone reduces morbidity and improves pulmonary function in cystic fibrosis. Lancet (1985) 3.32
Deprivation and cause specific morbidity: evidence from the Somerset and Avon survey of health. BMJ (1996) 3.18
Dihydrofolate reductase: x-ray structure of the binary complex with methotrexate. Science (1977) 2.88
Reliability of the Washington University in St. Louis Kiddie Schedule for Affective Disorders and Schizophrenia (WASH-U-KSADS) mania and rapid cycling sections. J Am Acad Child Adolesc Psychiatry (2001) 2.83
Final results from a meta-analysis of remedial interventions with drink/drive offenders. Addiction (1995) 2.66
Identification of inbred mouse strains harboring genetic modifiers of mammary tumor age of onset and metastatic progression. Int J Cancer (1998) 2.36
Double-blind and placebo-controlled study of lithium for adolescent bipolar disorders with secondary substance dependency. J Am Acad Child Adolesc Psychiatry (1998) 2.16
Incentive spirometry decreases respiratory complications following major abdominal surgery. Surgeon (2007) 2.15
Possible discrimination in recruitment of psychiatry residents? Am J Psychiatry (1997) 2.14
The adenosine/neutrophil paradox resolved: human neutrophils possess both A1 and A2 receptors that promote chemotaxis and inhibit O2 generation, respectively. J Clin Invest (1990) 2.12
Prepubertal and young adolescent bipolarity versus ADHD: assessment and validity using the WASH-U-KSADS, CBCL and TRF. J Affect Disord (1998) 2.10
Towards a revised nomenclature for P1 and P2 receptors. Trends Pharmacol Sci (1997) 2.09
British HIV Association guidelines for the routine investigation and monitoring of adult HIV-1-infected individuals 2011. HIV Med (2012) 2.05
Correlation between fragment size at D4F104S1 and age at onset or at wheelchair use, with a possible generational effect, accounts for much phenotypic variation in 4q35-facioscapulohumeral muscular dystrophy (FSHD) Hum Mol Genet (1995) 2.02
Adenosine receptors: pharmacology, structure-activity relationships, and therapeutic potential. J Med Chem (1992) 2.01
The segment polarity gene armadillo interacts with the wingless signaling pathway in both embryonic and adult pattern formation. Development (1991) 2.01
Quality of life measured by the St George's Respiratory Questionnaire and spirometry. Eur Respir J (2009) 1.99
CGS 21680C, an A2 selective adenosine receptor agonist with preferential hypotensive activity. J Pharmacol Exp Ther (1989) 1.99
Purine receptors in mammalian tissues: pharmacology and functional significance. Annu Rev Pharmacol Toxicol (1987) 1.97
Histopathology of the upper small intestines in typhoid fever. Biopsy study of experimental disease in man. Am J Dig Dis (1966) 1.97
Detection of single mammalian cells by high-resolution magnetic resonance imaging. Biophys J (1999) 1.90
Broad-spectrum, non-opioid analgesic activity by selective modulation of neuronal nicotinic acetylcholine receptors. Science (1998) 1.87
P2 purinergic receptors: modulation of cell function and therapeutic potential. J Pharmacol Exp Ther (2000) 1.85
Behavioural abnormalities and selective neuronal loss in HD transgenic mice expressing mutated full-length HD cDNA. Nat Genet (1998) 1.83
Activation of expression of hedgehog target genes in basal cell carcinomas. J Invest Dermatol (2001) 1.77
Macrophage accumulation associated with rat cardiac allograft rejection detected by magnetic resonance imaging with ultrasmall superparamagnetic iron oxide particles. Circulation (2001) 1.74
Psychosocial functioning in a prepubertal and early adolescent bipolar disorder phenotype. J Am Acad Child Adolesc Psychiatry (2000) 1.74
Peer discussion on training physicians to be competent communicators: support for a multiple discourse approach. South Med J (1997) 1.73
Identification of GS 4104 as an orally bioavailable prodrug of the influenza virus neuraminidase inhibitor GS 4071. Antimicrob Agents Chemother (1998) 1.72
A phosphatocopid crustacean with appendages from the Lower Cambrian. Science (2001) 1.70
Adherence by African American men to prostate cancer education and early detection. Cancer (1999) 1.69
Liver cells. Methods Enzymol (1979) 1.67
The carbon balance of Africa: synthesis of recent research studies. Philos Trans A Math Phys Eng Sci (2011) 1.65
Sensitivity of Shah, Vanclay and Cooper's modified Barthel Index. Clin Rehabil (1999) 1.62
Gene rearrangements in the diagnosis of lymphoma/leukemia. Guidelines for use based on a multiinstitutional study. Am J Clin Pathol (1991) 1.61
Diagnostic characteristics of 93 cases of a prepubertal and early adolescent bipolar disorder phenotype by gender, puberty and comorbid attention deficit hyperactivity disorder. J Child Adolesc Psychopharmacol (2000) 1.61
Neuronal nicotinic acetylcholine receptors as novel drug targets. J Pharmacol Exp Ther (2000) 1.60
Guidelines for pre-transfusion compatibility procedures in blood transfusion laboratories. British Committee for Standards in Haematology. Transfus Med (2012) 1.60
Bipolar disorder at prospective follow-up of adults who had prepubertal major depressive disorder. Am J Psychiatry (2001) 1.59
HIV risk behaviors associated with the injection process: multiperson use of drug injection equipment and paraphernalia in injection drug user networks. Subst Use Misuse (1998) 1.58
UK Back pain Exercise And Manipulation (UK BEAM) trial--national randomised trial of physical treatments for back pain in primary care: objectives, design and interventions [ISRCTN32683578]. BMC Health Serv Res (2003) 1.57
One minute wisdom. All you need to know about CS gas. Nurs Stand (1994) 1.55
Assessment of functional capacity in clinical and research applications: An advisory from the Committee on Exercise, Rehabilitation, and Prevention, Council on Clinical Cardiology, American Heart Association. Circulation (2000) 1.55
Autonomic orienting responses in 15-year-old male subjects and criminal behavior at age 24. Am J Psychiatry (1990) 1.54
Sale of sex for drugs and drugs for sex: an economic context of sexual risk behavior for STDs. Sex Transm Dis (1999) 1.53
Recent advances in understanding the pathogenesis of Huntington's disease. Trends Neurosci (1999) 1.53
CT appearances of talc pleurodesis. Clin Radiol (2007) 1.52
Identification of the A2 adenosine receptor binding subunit by photoaffinity crosslinking. Proc Natl Acad Sci U S A (1989) 1.50
Strong constraints on the rare decays B(s)(0) → μ+ μ- and B0 → μ+ μ-. Phys Rev Lett (2012) 1.50
First observation of the decays B(0) → D(+)K(-)π(+)π(-) and B(-) → D(0)K(-)π(+)π(-). Phys Rev Lett (2012) 1.50
22q13.3 deletion syndrome: clinical and molecular analysis using array CGH. Am J Med Genet A (2010) 1.49
Progression of cystic fibrosis lung disease as a function of serum immunoglobulin G levels: a 5-year longitudinal study. J Pediatr (1984) 1.48
The hypronosticon test in breast cancer. Clin Oncol (1975) 1.47
A familial hypertrophic cardiomyopathy locus maps to chromosome 15q2. Proc Natl Acad Sci U S A (1993) 1.47
Gut microbes define liver cancer risk in mice exposed to chemical and viral transgenic hepatocarcinogens. Gut (2010) 1.47
Beta 3-endonexin, a novel polypeptide that interacts specifically with the cytoplasmic tail of the integrin beta 3 subunit. J Cell Biol (1995) 1.46
Beta-adrenergic growth regulation of human cancer cell lines derived from pancreatic ductal carcinomas. Carcinogenesis (2001) 1.44
Improved therapies for Parkinson's disease: life beyond dopamine D2/D3 receptor agonists. Trends Pharmacol Sci (1997) 1.44
Agonist derived molecular probes for A2 adenosine receptors. J Mol Recognit (1989) 1.43
Determination of the X(3872) meson quantum numbers. Phys Rev Lett (2013) 1.42
An investigation of psychological distress in patients who have been treated for head and neck cancer. Br J Oral Maxillofac Surg (2001) 1.42
Phosphorylation-dephosphorylation of pyruvate dehydrogenase complex from pea leaf mitochondria. Arch Biochem Biophys (1981) 1.42
Assessing dopamine concentrations: an evidence-based approach. Am J Crit Care (2000) 1.41
Mutant huntingtin expression in clonal striatal cells: dissociation of inclusion formation and neuronal survival by caspase inhibition. J Neurosci (1999) 1.40
Is GIFT (gamete intrafallopian transfer) the best treatment for unexplained infertility? Br J Obstet Gynaecol (1991) 1.40
Maternal fatigue: implications of second stage labor nursing care. J Obstet Gynecol Neonatal Nurs (1999) 1.40
Nursing orientation: a continuous quality improvement story. Clin Nurse Spec (1996) 1.40
Hypogammaglobulinemia in patients with cystic fibrosis. N Engl J Med (1980) 1.40
Bayesian analysis of pentaquark signals from CLAS data. Phys Rev Lett (2008) 1.39
Adolescent health care: can an international approach help? Can Fam Physician (1990) 1.39
An international survey in postgraduate training in Oral Medicine. Oral Dis (2011) 1.39
Barriers and incentives for primary-care physicians in cancer prevention and detection. Cancer (1987) 1.38
Airway difficulties associated with severe epistaxis. Anaesthesia (1999) 1.38
Measurement of two- and three-nucleon short-range correlation probabilities in nuclei. Phys Rev Lett (2006) 1.37
Prepubertal and early adolescent bipolarity differentiate from ADHD by manic symptoms, grandiose delusions, ultra-rapid or ultradian cycling. J Affect Disord (1998) 1.36
Attenuation of diet-induced atherosclerosis in rabbits with a highly selective 15-lipoxygenase inhibitor lacking significant antioxidant properties. Br J Pharmacol (1997) 1.35
The electrocardiogram predicts one-year outcome of patients with unstable angina and non-Q wave myocardial infarction: results of the TIMI III Registry ECG Ancillary Study. Thrombolysis in Myocardial Ischemia. J Am Coll Cardiol (1997) 1.34
2-(Arylalkylamino)adenosin-5'-uronamides: a new class of highly selective adenosine A2 receptor ligands. J Med Chem (1990) 1.34
Novel 3-Pyridyl ethers with subnanomolar affinity for central neuronal nicotinic acetylcholine receptors. J Med Chem (1996) 1.33
Crowd influence on decisions in association football. Lancet (1999) 1.33
Disruption of the varicella-zoster virus dUTPase and the adjacent ORF9A gene results in impaired growth and reduced syncytia formation in vitro. Virology (1997) 1.32
An insight into early reproductive processes through the in vivo model of ovum donation. J Clin Endocrinol Metab (1991) 1.31
Relation of renal gluconeogenesis to ammonia production in the dog. Am J Physiol (1970) 1.31
The reliability of selected pain provocation tests for sacroiliac joint pathology. Spine (Phila Pa 1976) (1994) 1.30
The self-reporting of cocaine use. JAMA (1992) 1.29